Concord Drugs Ltd manufactures licensed drugs based on approved formulationsProduct Portfolio: a) Pharmaceutical Ready to fill Pellets b) Multiple Unit Pellet System (MUPS) c) Tissue Bio Adhesive d) Injectables (Small Volume Parenterals) e) Oral Solid Dosages (Tablets & Capsules) f) Liquid Orals (Syrups & Suspensions) g) Dry Syrup (Powder)
Concord Drugs has announced that its upcoming annual general meeting will take place via video conferencing, alongside temporary closures of the register of members and share transfer books for scheduling purposes. Shareholders are provided electronic voting access through a designated depository platform to cast votes ahead of the meeting. These...
Concord Drugs has announced that physical letters are being dispatched to shareholders whose email addresses are not registered, providing the web link and navigation path to access the annual report and upcoming annual general meeting details. This outreach ensures that unregistered investors can view corporate disclosures and underscores the company's...
Concord Drugs Ltd has announced that its Register of Members and Share Transfer Books will temporarily close to prepare for its upcoming 31st Annual General Meeting. Shareholders holding shares as of the designated cut-off date will be eligible to cast their votes electronically during the meeting. This temporary closure is...
Concord Drugs Ltd has announced that its Register of Members and Share Transfer Books will temporarily close to prepare for its upcoming thirty-first Annual General Meeting. This temporary closure helps finalize the official roster of shareholders. Additionally, the company has set a specific cut-off date to determine which shareholders are...
